Genmab
GMAB
£16.92
Share price
-2.12%
Change (1 day)
-23.72%
Change (1 year)
Categories
EPS for Genmab (GMAB)
EPS in 2025 (TTM): £3.69
According to Genmab's latest financial reports the company's current EPS (TTM) is £3.58. In 2024 the company made an earnings per share (EPS) of £9.15 an increase over its 2023 EPS that were of £4.99.
EPS history for Genmab from 2002 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | £3.69 | -59.69% |
| 2024 | £9.15 | 83.39% |
| 2023 | £4.99 | -21.09% |
| 2022 | £6.32 | 83.59% |
| 2021 | £3.44 | -36.99% |
| 2020 | £5.47 | 112.21% |
| 2019 | £2.58 | 43.15% |
| 2018 | £1.80 | 32.47% |
| 2017 | £1.36 | -8.52% |
| 2016 | £1.48 | 51.95% |
| 2015 | £0.98 | 143.93% |
| 2014 | £0.40 | 143.18% |
| 2013 | £0.16 | -120.79% |
| 2012 | -£0.79 | -20.33% |
| 2011 | -£0.99 | 85.47% |
| 2010 | -£0.54 | -68.19% |
| 2009 | -£1.69 | 4.12% |
| 2008 | -£1.62 | 147.94% |
| 2007 | -£0.65 | -22.56% |
| 2006 | -£0.84 | -10.56% |
| 2005 | -£0.94 | -19.76% |
| 2004 | -£1.17 | 9.49% |
| 2003 | -£1.07 | -33.35% |
| 2002 | -£1.61 |